ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 1 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,551,263 | +18.3% | 10,963,158 | +40.3% | 0.31% | -7.0% |
| Q2 2023 | $7,226,588 | +22.0% | 7,812,528 | +43.7% | 0.33% | -1.8% |
| Q1 2023 | $5,924,629 | -23.2% | 5,435,439 | +2.9% | 0.34% | -37.0% |
| Q4 2022 | $7,714,113 | +49.8% | 5,283,639 | +10.3% | 0.53% | +6.0% |
| Q3 2022 | $5,149,000 | -35.3% | 4,789,490 | +2.4% | 0.50% | -39.8% |
| Q2 2022 | $7,955,000 | -12.8% | 4,679,491 | +5.6% | 0.83% | -28.9% |
| Q1 2022 | $9,125,000 | +12.5% | 4,429,491 | +104.8% | 1.17% | +9.2% |
| Q4 2021 | $8,109,000 | – | 2,162,313 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |